<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Reprod Biol Endocrinol</journal-id><journal-title>Reproductive biology and endocrinology : RB&#x00026;E</journal-title><issn pub-type="epub">1477-7827</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1477-7827-6-38</article-id><article-id pub-id-type="pmid">18768081</article-id><article-id pub-id-type="doi">10.1186/1477-7827-6-38</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>The genetics of feto-placental development: A study of acid phosphatase locus 1 and adenosine deaminase polymorphisms in a consecutive series of newborn infants</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Gloria-Bottini</surname><given-names>Fulvia</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>gloria@med.uniroma2.it</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Pietropolli</surname><given-names>Adalgisa</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>pietropolli@med.uniroma2.it</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Coppeta</surname><given-names>Luca</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>lcoppeta@tiscali.it</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Magrini</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>andrea.magrini@uniroma2.it</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Bergamaschi</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>antonio.bergamaschi@rm.unicatt.it</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Bottini</surname><given-names>Egidio</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>bottini@med.uniroma2.it</email></contrib></contrib-group><aff id="I1"><label>1</label>Division of Human Population Biopathology and Environmental Pathology, Department of Biopathology and Imaging Diagnostics, University of Rome Tor Vergata, Rome, Italy</aff><aff id="I2"><label>2</label>Division of Obstetrics and Gynecology, Department of Surgery, University of Rome Tor Vergata, School of Medicine, Rome, Italy</aff><aff id="I3"><label>3</label>Institute of Occupational Health Medicine, Catholic University of Holy Hearth, Rome, Italy</aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>3</day><month>9</month><year>2008</year></pub-date><volume>6</volume><fpage>38</fpage><lpage>38</lpage><ext-link ext-link-type="uri" xlink:href="http://www.rbej.com/content/6/1/38"/><history><date date-type="received"><day>14</day><month>1</month><year>2008</year></date><date date-type="accepted"><day>3</day><month>9</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Gloria-Bottini et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Gloria-Bottini et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Gloria-Bottini Fulvia gloria@med.uniroma2.it </dc:author><dc:title> The genetics of feto-placental development: A study of acid phosphatase locus 1 and adenosine deaminase polymorphisms in a consecutive series of newborn infants </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>Reproductive Biology and Endocrinology 6(1): 38-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1477-7827(2008)6:1&#x0003c;38&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1477-7827</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Acid phosphatase locus 1 and adenosine deaminase locus 1 polymorphisms show cooperative effects on glucose metabolism and immunological functions. The recent observation of cooperation between the two systems on susceptibility to repeated spontaneous miscarriage prompted us to search for possible interactional effects between these genes and the correlation between birth weight and placental weight. Deviation from a balanced development of the feto-placental unit has been found to be associated with perinatal morbidity and mortality and with cardiovascular diseases in adulthood.</p></sec><sec sec-type="methods"><title>Methods</title><p>We examined 400 consecutive newborns from the Caucasian population of Rome. Birth weight, placental weight, and gestational length were registered. Acid phosphatase locus 1 and adenosine deaminase locus 1 phenotypes were determined by starch gel electrophoresis and correlation analysis was performed by SPSS programs. Informed verbal consent to participate in the study was obtained from the mothers.</p></sec><sec><title>Results</title><p>Highly significant differences in birth weight-placental weight correlations were observed among acid phosphatase locus 1 phenotypes (p = 0.005). The correlation between birth weight and placental weight was markedly elevated in subjects carrying acid phosphatase locus 1 phenotypes with medium-low F isoform concentration (A, CA and CB phenotypes) compared to those carrying acid phosphatase locus 1 phenotypes with medium-high F isoform concentration (BA and B phenotypes) (p = 0.002). Environmental and developmental variables were found to exert a significant effect on birth weight-placental weight correlation in subjects with medium-high F isoform concentrations, but only a marginal effect was observed in those with medium-low F isoform concentrations. The correlation between birth weight and placental weight is higher among carriers of the adenosine deaminase locus 1 allele*2, which is associated with low activity, than in homozygous adenosine deaminase locus 1 phenotype 1 carriers (p = 0.04). The two systems show a cooperative effect on the correlation between birth weight and placental weight: the highest value is observed in newborns carrying adenosine deaminase locus 1 allele*2 and acid phosphatase locus 1 phenotypes with medium-low F isoform concentration (p = 0.005).</p></sec><sec><title>Conclusion</title><p>These data suggest that zygotes with low adenosine deaminase locus 1 activity and low F activity may experience the most favourable intrauterine conditions for a balanced development of the feto-placental unit.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>We have recently described a cooperative interaction between ACP<sub>1 </sub>(acid phosphatase locus 1) and ADA<sub>1 </sub>(adenosine deaminase locus 1) genetic polymorphisms concerning their effects on the susceptibility to spontaneous primary repeated miscarriages: women carrying the ADA<sub>1</sub>*2 and ACP<sub>1</sub>*C alleles show the lowest susceptibility to repeated miscarriages [<xref ref-type="bibr" rid="B1">1</xref>]. Both systems share important effects on glucose metabolism and immunological function. These observations prompted us to search for a possible cooperative interaction between the two systems regarding their effects on developmental parameters during intrauterine life.</p><p>It is likely that a balanced growth of the two portions of the feto-placental unit (i.e. without the prevalence of placental on the fetal part or vice versa) represents an advantage for fetal development. The birth weight/placental weight ratio (BW/PW) has been found to be correlated with perinatal morbidity and mortality and with cardiovascular disease in adulthood [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>]. There is evidence that in addition to maternal factors and socioeconomic status, genetic factors also influence the ratio BW/PW [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref>]. In a recent note we have proposed the correlation between BW and PW as an index of balanced development of the feto-placental unit and have shown that this correlation is influenced by ACP<sub>1 </sub>phenotype [<xref ref-type="bibr" rid="B6">6</xref>].</p><sec><title>The ACP<sub>1 </sub>genetic polymorphism</title><p>ACP<sub>1 </sub>also called low molecular weight phospho-protein tyrosine phosphatase (LMPTP) is an enzyme controlled by a locus on chromosome 2 showing three common alleles: ACP<sub>1</sub>*A, ACP<sub>1</sub>*B, ACP<sub>1</sub>*C. These three alleles are associated with different enzymatic activities [<xref ref-type="bibr" rid="B7">7</xref>]. Activity of ACP<sub>1 </sub>phenotypes are in te following order: A &#x0003c; BA &#x0003c; B = CA &#x0003c; CB &#x0003c; C [<xref ref-type="bibr" rid="B8">8</xref>].</p><p>Each allele at the ACP<sub>1 </sub>locus encodes two isoforms, called F (fast) and S (slow) [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. ACP<sub>1 </sub>B and BA show a medium-high F isoform activity while CB, A, CA and C phenotypes show a medium-low F isoform activity. ACP<sub>1 </sub>C, CA and CB show a much higher activity of S isoform as compared to other ACP<sub>1 </sub>phenotypes [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B10">10</xref>].</p><p>Two important functions have been suggested for ACP<sub>1</sub>: flavin-mono-nucleotide phosphatase activity and tyrosine phosphatase activity [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B13">13</xref>]. Catalysing the conversion of flavin-mononucleotide (FMN) to riboflavin, ACP<sub>1 </sub>may have a role in regulating the cellular concentration of flavin-adenine-dinucleotide (FAD), flavo-enzyme activity and energy metabolism. As a phosphotyrosine phosphatase, the enzyme may have an important role in cellular growth regulation and in modulation of glycolytic rate through the control of receptor activities and of band 3 protein phosphorylation status [[<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B14">14</xref>] and [<xref ref-type="bibr" rid="B15">15</xref>]].</p><p>Recently it has been shown that ACP<sub>1 </sub>specifically dephosphorylates the negative regulatory Tyr-292 of ZAP-70, thereby counteracting inactivation of ZAP-70. The ZAP-70 protein-tyrosine kinase plays a central role in signalling from the T cell receptor. Thus, these results indicate that ACP<sub>1 </sub>strengthens T cell receptor signalling [<xref ref-type="bibr" rid="B16">16</xref>].</p></sec><sec><title>The ADA<sub>1 </sub>genetic polymorphism</title><p>ADA<sub>1 </sub>is a polymorphic enzyme present in all mammalian tissues [<xref ref-type="bibr" rid="B17">17</xref>]. It is controlled by a locus with two codominant alleles ADA*1 and ADA*2 located on the long arm of chromosome 20. The corresponding three common ADA<sub>1 </sub>phenotypes have different enzymatic activities: the ADA<sub>1</sub>1 phenotype is 15% more active than the ADA<sub>1</sub>2/1 phenotype and 30% more active than the ADA<sub>1</sub>2 phenotype, which is very rare [<xref ref-type="bibr" rid="B18">18</xref>].</p><p>ADA<sub>1 </sub>catalyses the irreversible deamination of adenosine to inosine. Red Blood Cells (RBC) are in equilibrium with freely diffusing adenosine [<xref ref-type="bibr" rid="B19">19</xref>], pointing to an important role for this enzyme in the regulation of adenosine concentration.</p><p>Current interest has been focused on a wide variety of effects produced by adenosine via activation of cell surface adenosine receptors [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. Adenosine counteracts insulin action in the liver by activating A2B receptors [<xref ref-type="bibr" rid="B22">22</xref>]. Adenosine seems to facilitate insulin action in adipocytes.</p><p>The adenosine deaminase complex protein [<xref ref-type="bibr" rid="B23">23</xref>] (ADPC) is identical with CD26, a T cell activating antigen and with a glycoprotein present in epithelial cells of various tissues. Recent data suggest that ADA<sub>1 </sub>and CD26 are co-localized on the T cell surface but not inside cells.</p><p>Cells expressing ADA<sub>1 </sub>and CD26 on the surface are much more resistant to the inhibitory effects of adenosine. These data suggest that ADA<sub>1 </sub>on the cell surface is involved in an important immunoregulatory mechanism by which released ADA<sub>1 </sub>binds to the cell surface of CD26, and this complex is capable of reducing the local concentration of adenosine [<xref ref-type="bibr" rid="B24">24</xref>].</p><p>In the present paper we have performed a more detailed analysis of the effect of ACP<sub>1 </sub>polymorphism and have extended this study to the ADA<sub>1 </sub>polymorphism. On the basis of the observations on women with repeated spontaneous miscarriages we would expect an optimal developmental context in zygotes carrying the ADA<sub>1</sub>*2 and ACP<sub>1</sub>*C alleles.</p></sec></sec><sec sec-type="methods"><title>Methods</title><p>In the present study we examined 400 consecutive newborn infants from healthy puerperae. All infants were Caucasian from the population of Rome. Birth weight and placental weight (wet, untrimmed) were registered in the delivery room. Gestational length was estimated from the date of the last menstrual period and checked against Dubowitz score as an additional index of neonatal maturity. Multiples were excluded. Mode of delivery does not alter the phenotype of enzyme considered.</p><p>The data presented in the paper were collected a few years ago and at that time there was not an established Ethical Committee. The project was discussed and approved in the Department. Informed verbal consent to participate in the study was obtained from the mothers. This has been recently (April 28, 2008) approved by the Institutional Ethical Committee.</p><p>Newborn blood samples were obtained from the placental side of the umbilical vein after umbilical cord section. The ACP<sub>1 </sub>phenotype was determined in 361 newborns by starch gel electrophoresis on red blood cell hemolysates according to Harris and Hopkinson [<xref ref-type="bibr" rid="B25">25</xref>]. The acid phosphatase pattern is revealed by a solution of phenolphtalein diphosphate: the addition of ammonium solution reveals the area where phenolphtalein has been liberated in the areas of gel where ACP<sub>1 </sub>activity is present. In European populations the presence of three common alleles *A, *B and *C determines the occurrence of six phenotypes: A, AB, B, AC, BC and C. Each of the homozygous A, B and C phenotypes are composed of two fractions, F and S, corresponding to fast and slow components of the electrophoretic pattern. Heterozygous phenotypes have a pattern corresponding to a mixture of homozygous types.</p><p>The ADA<sub>1 </sub>phenotype was determined by starch gel electrophoresis on red blood cell hemolysates according to Spencer et al [<xref ref-type="bibr" rid="B26">26</xref>]. Inosine produced at the sites of ADA<sub>1 </sub>activity is converted in hypoxanthine in the presence of nucleoside phosphorylase and phosphate. The hypoxanthine is then oxidized by the action of xanthine oxidase, and during this reaction the tetrazolium salt MTT is reduced in the presence of phenazine methosulphate to a blue insoluble formazan. In the ADA<sub>1</sub>1 type there are three regularly spaced components which exhibit decreasing staining intensity in order of their anodal electrophoretic mobilities. In the ADA<sub>1</sub>2 type there are also three isozymes and their relative intensities and relative electrophoretic mobilities are very similar to those of the ADA<sub>1</sub>1 pattern. The difference between ADA<sub>1</sub>1 and ADA<sub>1</sub>2 is that the ADA<sub>1</sub>2 pattern is appreciably slower than the ADA<sub>1</sub>1 pattern. The pattern exhibiting four isozymes, designated ADA<sub>1</sub>2/1, has the appearance of a mixture of ADA<sub>1</sub>1 and ADA<sub>1</sub>2 patterns.</p><p>In the last few years, in our laboratory, determination of ADA<sub>1 </sub>and ACP<sub>1 </sub>genotypes has been performed routinely on DNA. In our laboratory the comparison of classical with DNA methods has shown practically no differences between phenotypic and genotypic classifications. On a sample of 50 subjects in which ACP<sub>1 </sub>and ADA<sub>1 </sub>phenotypes were determined by DNA and classical methods only one difference was observed for ACP<sub>1 </sub>and no difference for ADA<sub>1</sub>.</p><p>Correlation analysis was performed by SPSS programs. Differences between correlation coefficients were evaluated according to Snedecor and Cochran [<xref ref-type="bibr" rid="B27">27</xref>]. The distribution of ACP<sub>1 </sub>phenotypes among newborns does not differ statistically from Hardy-Weinberg expectation.</p></sec><sec><title>Results</title><p>Table <xref ref-type="table" rid="T1">1</xref> shows demographic parameters of the sample study. Table <xref ref-type="table" rid="T2">2</xref> shows the distribution of ACP<sub>1 </sub>phenotypes and developmental parameters for each phenotype. No statistical significant difference among ACP<sub>1 </sub>phenotypes is observed for BW, PW and gestational duration. CA phenotype shows low values for all parameters, but these values are not statistically different from those of other ACP<sub>1 </sub>phenotypes. BW-PW correlation analysis shows highly significant differences among ACP<sub>1 </sub>phenotypes. The highest correlation coefficient is observed for CA phenotype and the lowest for B phenotype.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Maternal and neonatal parameters in the sample study</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left">Mean</td><td align="left">Proportion</td><td align="left">S.E.</td></tr></thead><tbody><tr><td align="left">Maternal Age (yrs)</td><td align="left">28.5</td><td></td><td align="left">0.3</td></tr><tr><td align="left">Gestational Age (wks)</td><td align="left">39.6</td><td></td><td align="left">0.12</td></tr><tr><td align="left">Birth Weight (gr)</td><td align="left">3269</td><td></td><td align="left">29</td></tr><tr><td align="left">Placental Weight (gr)</td><td align="left">578</td><td></td><td align="left">8</td></tr><tr><td align="left">Smokers</td><td></td><td align="left">38%</td><td></td></tr><tr><td align="left">Male Infant</td><td></td><td align="left">54%</td><td></td></tr></tbody></table></table-wrap><p>Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2</xref>, <xref ref-type="fig" rid="F3">3</xref>, and <xref ref-type="fig" rid="F4">4</xref> illustrate the relationship between BW-PW correlation and relevant ACP<sub>1 </sub>parameters: F and S activity, F/S activity ratio and total activity. The BW-PW correlation is negatively associated with F concentration (Fig <xref ref-type="fig" rid="F1">1</xref>) and F/S ratio (Fig <xref ref-type="fig" rid="F3">3</xref>). A, CA and CB phenotypes that share a medium-low F activity and F/S ratio have a high BW-PW correlation, while the B phenotype, which has the highest F activity and F/S ratio, has a low BW-PW correlation. No association is observed for S isoform concentration (Fig <xref ref-type="fig" rid="F2">2</xref>) and ACP<sub>1 </sub>total activity (Fig <xref ref-type="fig" rid="F4">4</xref>).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Distribution of neonatal parameters in relation to ACP<sub>1 </sub>phenotypes.</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="6">ACP<sub>1 </sub>phenotypes</td><td align="center">Significance of difference among phenotypes (p)</td></tr><tr><td></td><td colspan="6"><hr></hr></td><td></td></tr><tr><td></td><td align="left">A</td><td align="left">B</td><td align="left">C</td><td align="left">BA</td><td align="left">CA</td><td align="left">CB</td><td></td></tr><tr><td colspan="7"><hr></hr></td><td></td></tr><tr><td align="left">Absolute frequencies</td><td align="left">34</td><td align="left">163</td><td align="left">2</td><td align="left">123</td><td align="left">9</td><td align="left">30</td><td></td></tr><tr><td colspan="7"><hr></hr></td><td></td></tr><tr><td align="left">Percent frequencies</td><td align="left">9.4%</td><td align="left">45.2%</td><td align="left">0.6%</td><td align="left">34.1%</td><td align="left">2.5%</td><td align="left">8.3%</td><td></td></tr></thead><tbody><tr><td align="left"><italic>Birth weight (gr)</italic></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="8"><hr></hr></td></tr><tr><td align="center">Mean</td><td align="left">3345</td><td align="left">3250</td><td align="left">3645</td><td align="left">3338</td><td align="left">2837</td><td align="left">3244</td><td align="center">0.141 (*)</td></tr><tr><td align="center">S.E.</td><td align="left">85</td><td align="left">46</td><td align="left">575</td><td align="left">44</td><td align="left">333</td><td align="left">90</td><td></td></tr><tr><td colspan="8"><hr></hr></td></tr><tr><td align="left"><italic>Placental weight(gr)</italic></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="8"><hr></hr></td></tr><tr><td align="center">Mean</td><td align="left">590</td><td align="left">594</td><td align="left">615</td><td align="left">571</td><td align="left">517</td><td align="left">540</td><td align="center">0.491(*)</td></tr><tr><td align="center">S.E.</td><td align="left">23</td><td align="left">17</td><td align="left">135</td><td align="left">12</td><td align="left">46</td><td align="left">21</td><td></td></tr><tr><td colspan="8"><hr></hr></td></tr><tr><td align="left"><italic>Gestational age(wks)</italic></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="8"><hr></hr></td></tr><tr><td align="center">Mean</td><td align="left">40.00</td><td align="left">39.61</td><td align="left">39.50</td><td align="left">39.77</td><td align="left">38.11</td><td align="left">39.53</td><td align="center">0.405(*)</td></tr><tr><td align="center">S.E.</td><td align="left">0.41</td><td align="left">0.20</td><td align="left">1.50</td><td align="left">0.15</td><td align="left">1.57</td><td align="left">0.40</td><td></td></tr><tr><td align="center">Median</td><td align="left">40.00</td><td align="left">40.00</td><td align="left">39.50</td><td align="left">40.00</td><td align="left">40.00</td><td align="left">40.00</td><td></td></tr><tr><td colspan="8"><hr></hr></td></tr><tr><td align="left">Correlation between birth weight and placental weight (r)</td><td align="left">0.69</td><td align="left">0.18</td><td align="left">-</td><td align="left">0.31</td><td align="left">0.77</td><td align="left">0.68</td><td align="center">0.005(**)</td></tr><tr><td align="left">Significance of r (p)</td><td align="left">0.001</td><td align="left">0.029</td><td align="left">-</td><td align="left">0.001</td><td align="left">0.025</td><td align="left">0.001</td><td></td></tr></tbody></table><table-wrap-foot><p>Significance of differences among means (*) refers to Variance analysis. Significance of differences among correlation coefficients (**) has been calculated according to Snedecor and Cochran.</p></table-wrap-foot></table-wrap><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>The relationship between F isoform concentration and BW-PW correlation</bold>. The term BW-PW correlation expresses the correlation between birth weight and placental weight. ACP1 is the acid phosphatase locus 1. A, B, C, BA, CA, CB are the ACP<sub>1 </sub>phenotypes. In abscissa F isoform concentrations of each ACP<sub>1 </sub>phenotype are also reported. The rank correlation coefficient according to Spearman (27) between BW-PW correlation and F isoform concentration is r<sub>s </sub>= -1, p &#x0003c; 0.01.</p></caption><graphic xlink:href="1477-7827-6-38-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>The relationship between S isoform concentration and BW-PW correlation</bold>. The term BW-PW correlation expresses the correlation between birth weight and placental weight. ACP1 is the acid phosphatase locus 1. A, B, C, BA, CA, CB are the ACP<sub>1 </sub>phenotypes. In abscissa S isoform concentrations of each ACP<sub>1 </sub>phenotype are also reported. The rank correlation coefficient according to Spearman (27) between BW-PW correlation and S isoform concentration is r<sub>s </sub>= 0.3, p not significant.</p></caption><graphic xlink:href="1477-7827-6-38-2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>The relationship between F/S isoform concentration and BW-PW correlation</bold>. The term BW-PW correlation expresses the correlation between birth weight and placental weight. ACP1 is the acid phosphatase locus 1. A, B, C, BA, CA, CB are the ACP<sub>1 </sub>phenotypes. In abscissa F/S isoform concentrations of each ACP<sub>1 </sub>phenotype are also reported. The rank correlation coefficient according to Spearman (27) between BW-PW correlation and F/S isoform concentration is r<sub>s </sub>= -0.9, p &#x0003c; 0.05.</p></caption><graphic xlink:href="1477-7827-6-38-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>The relationship between F+S isoform concentration and BW-PW correlation</bold>. The term BW-PW correlation expresses the correlation between birth weight and placental weight. ACP1 is the acid phosphatase locus 1. A, B, C, BA, CA, CB are the ACP<sub>1 </sub>phenotypes. In abscissa F+S isoform concentrations of each ACP<sub>1 </sub>phenotype are also reported. The rank correlation coefficient according to Spearman (27) between BW-PW correlation and F+S isoform concentration is r<sub>s </sub>= 0.3, p not significant.</p></caption><graphic xlink:href="1477-7827-6-38-4"/></fig><p>Table <xref ref-type="table" rid="T3">3</xref> shows the effect of smoking, maternal age, gestational age, parity and gender on the relationship between ACP<sub>1 </sub>and BW-PW correlation. For this analysis two classes of ACP<sub>1 </sub>phenotypes have been considered: A, CA, CB phenotypes with medium-low F activity, and B and BA phenotypes with medium-high F activity. In A, CA, CB phenotypes only maternal age exhibits some effect on the BW-PW correlation, while among B and BA phenotypes most variables show highly significant effects on the BW-PW correlation.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Correlation between birth weight and placental weight in relation to ACP<sub>1 </sub>F isoform activity.</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="4">ACP<sub>1 </sub>F isoform activity</td></tr></thead><tbody><tr><td align="left">Sample</td><td align="left" colspan="2">&#x02003;Medium-high (B+BA)</td><td align="left" colspan="2">&#x02003;Medium-low (A+CA+CB)</td></tr><tr><td></td><td colspan="4"><hr></hr></td></tr><tr><td></td><td align="left">r</td><td align="left">p*</td><td align="left">r</td><td align="center">p*</td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><italic>All subjects</italic></td><td align="left">0.209</td><td align="left">0.001</td><td align="left">0.687</td><td align="center">0.000</td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><italic>Smoking</italic></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="right">&#x02003;Yes</td><td align="left">0.122</td><td align="left">0.243</td><td align="left">0.696</td><td align="center">0.000</td></tr><tr><td align="right">no</td><td align="left">0.241</td><td align="left">0.002</td><td align="left">0.710</td><td align="center">0.000</td></tr><tr><td align="right">Significance of difference p**</td><td align="left">0.000</td><td></td><td align="left">0.750</td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><italic>Maternal age (yrs)</italic></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="right">&#x02264;28</td><td align="left">0.027</td><td align="left">0.745</td><td align="left">0.723</td><td align="center">0.000</td></tr><tr><td align="right">&#x0003e;28</td><td align="left">0.478</td><td align="left">0.000</td><td align="left">0.640</td><td align="center">0.000</td></tr><tr><td align="right">Significance of difference p**</td><td align="left">0.000</td><td></td><td align="left">0.025</td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><italic>Gestational age (wks)</italic></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="right">&#x02264;37</td><td align="left">0.183</td><td align="left">0.440</td><td align="left">0.731</td><td align="center">0.160</td></tr><tr><td align="right">&#x0003e;37</td><td align="left">0.228</td><td align="left">0.000</td><td align="left">0.655</td><td align="center">0.000</td></tr><tr><td align="right">Significance of difference p**</td><td align="left">0.450</td><td></td><td align="left">0.950</td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><italic>Birth order</italic></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="right">1</td><td align="left">0.305</td><td align="left">0.001</td><td align="left">0.672</td><td align="center">0.000</td></tr><tr><td align="right">&#x02265; 2</td><td align="left">0.158</td><td align="left">0.060</td><td align="left">0.703</td><td align="center">0.000</td></tr><tr><td align="right">Significance of difference p**</td><td align="left">0.000</td><td></td><td align="left">0.350</td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><italic>Sex</italic></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="right">male</td><td align="left">0.171</td><td align="left">0.044</td><td align="left">0.712</td><td align="center">0.000</td></tr><tr><td align="right">female</td><td align="left">0.301</td><td align="left">0.001</td><td align="left">0.655</td><td align="center">0.000</td></tr><tr><td align="right">Significance of difference p**</td><td align="left">0.000</td><td></td><td align="left">0.170</td><td></td></tr></tbody></table><table-wrap-foot><p>Significance of difference between correlation coefficients has been calculated according to Snedecor and Cochran. p* refers to significance of correlation coefficient. p** refers to significance of difference between the two classes. For "All subjects" the difference of correlation coefficients between (B+BA) vs (A+CA+CB) i.e. 0.209 vs 0.687 is highly significant: p = 0.002.</p></table-wrap-foot></table-wrap><p>Table <xref ref-type="table" rid="T4">4</xref> shows the distribution of ADA<sub>1 </sub>phenotypes and developmental parameters for the ADA<sub>1</sub>1 phenotype and for carriers of the ADA<sub>1</sub>*2 allele. The BW-PW correlation coefficient is higher among carriers of the ADA<sub>1</sub>*2 allele than among ADA<sub>1</sub>1 phenotype carriers (p = 0.04). No significant difference between ADA<sub>1 </sub>phenotypes has been observed for BW, PW and gestational duration.</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Parameters distribution of newborns in relation to ADA<sub>1 </sub>phenotypes.</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="2">ADA<sub>1 </sub>phenotypes</td><td align="center">Significance of difference between phenotypes (p)</td></tr><tr><td></td><td colspan="2"><hr></hr></td><td></td></tr><tr><td></td><td align="left">ADA<sub>1</sub>1</td><td align="left">(ADA<sub>1</sub>2/1+ADA<sub>1</sub>2)</td><td></td></tr><tr><td colspan="3"><hr></hr></td><td></td></tr><tr><td align="left">Absolute frequencies</td><td align="left">317</td><td align="left">58</td><td></td></tr><tr><td colspan="3"><hr></hr></td><td></td></tr><tr><td align="left">Percent frequencies</td><td align="left">84.5%</td><td align="left">15.5%</td><td></td></tr></thead><tbody><tr><td align="left"><italic>Birth weight (gr)</italic></td><td></td><td></td><td></td></tr><tr><td colspan="4"><hr></hr></td></tr><tr><td align="center">Mean</td><td align="left">3279</td><td align="left">3311</td><td align="center">0.612*</td></tr><tr><td align="center">S.E.</td><td align="left">32</td><td align="left">54</td><td></td></tr><tr><td colspan="4"><hr></hr></td></tr><tr><td align="left"><italic>Placental weight (gr)</italic></td><td></td><td></td><td></td></tr><tr><td colspan="4"><hr></hr></td></tr><tr><td align="center">Mean</td><td align="left">584</td><td align="left">545</td><td align="center">0.103*</td></tr><tr><td align="center">S.E.</td><td align="left">10</td><td align="left">13</td><td></td></tr><tr><td colspan="4"><hr></hr></td></tr><tr><td align="left"><italic>Gestational age (wks)</italic></td><td></td><td></td><td></td></tr><tr><td colspan="4"><hr></hr></td></tr><tr><td align="center">Mean</td><td align="left">39.63</td><td align="left">39.84</td><td align="center">0.505*</td></tr><tr><td align="center">S.E.</td><td align="left">0.13</td><td align="left">0.24</td><td></td></tr><tr><td align="center">Median</td><td align="left">40.00</td><td align="left">40.00</td><td></td></tr><tr><td colspan="4"><hr></hr></td></tr><tr><td align="left">Correlation between birth weight and placental weight (r)</td><td align="left">0.289</td><td align="left">0.552</td><td align="center">0.040**</td></tr><tr><td align="left">Significance of r (p)</td><td align="left">0.000</td><td align="left">0.000</td><td></td></tr></tbody></table><table-wrap-foot><p>Significance of difference between means (*) refers to Variance analysis. Significance of difference between correlation coefficients (**) has been calculated according to Snedecor and Cochran</p></table-wrap-foot></table-wrap><p>Table <xref ref-type="table" rid="T5">5</xref> shows the effect of smoking, maternal age, gestational age, parity and gender on the relationship between ADA<sub>1 </sub>and BW-PW correlation. Significant effects of these variables were observed in the correlations of BW-PW in both ADA<sub>1 </sub>subjects and in carriers of the ADA<sub>1</sub>*2 allele.</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Correlation between birth weight and placental weight in relation to ADA<sub>1 </sub>phenotypes.</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="4">ADA<sub>1 </sub>phenotypes</td></tr><tr><td></td><td colspan="4"><hr></hr></td></tr><tr><td align="center">Sample</td><td align="left" colspan="2">&#x02003;&#x02003;&#x02003;ADA<sub>1</sub>1</td><td align="left" colspan="2">&#x02003;&#x02003;&#x02003;(ADA<sub>1</sub>2/1+ADA<sub>1</sub>2)</td></tr><tr><td></td><td colspan="4"><hr></hr></td></tr><tr><td></td><td align="left">r</td><td align="left">p*</td><td align="left">r</td><td align="center">p*</td></tr></thead><tbody><tr><td align="left"><italic>All subjects</italic></td><td align="left">0.289</td><td align="left">0.000</td><td align="left">0.552</td><td align="center">0.000</td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><italic>Smoking</italic></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="right">Yes</td><td align="left">0.275</td><td align="left">0.003</td><td align="left">0.484</td><td align="center">0.036</td></tr><tr><td align="right">no</td><td align="left">0.288</td><td align="left">0.000</td><td align="left">0.589</td><td align="center">0.000</td></tr><tr><td align="right">Significance of difference p**</td><td align="left">0.300</td><td></td><td align="left">0.150</td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><italic>Maternal age (yrs)</italic></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="right">&#x02264;28</td><td align="left">0.104</td><td align="left">0.181</td><td align="left">0.679</td><td align="center">0.000</td></tr><tr><td align="right">&#x0003e;28</td><td align="left">0.559</td><td align="left">0.000</td><td align="left">0.341</td><td align="center">0.120</td></tr><tr><td align="right">Significance of difference p**</td><td align="left">0.000</td><td></td><td align="left">0.000</td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><italic>Gestational age (wks)</italic></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="right">&#x02264;37</td><td align="left">0.292</td><td align="left">0.187</td><td align="left">0.922</td><td align="center">0.078</td></tr><tr><td align="right">&#x0003e;37</td><td align="left">0.286</td><td align="left">0.000</td><td align="left">0.560</td><td align="center">0.000</td></tr><tr><td align="right">Significance of difference p**</td><td align="left">0.900</td><td></td><td align="left">0.350</td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><italic>Birth order</italic></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="right">1</td><td align="left">0.449</td><td align="left">0.000</td><td align="left">0.572</td><td align="center">0.001</td></tr><tr><td align="right">&#x02265; 2</td><td align="left">0.212</td><td align="left">0.009</td><td align="left">0.543</td><td align="center">0.003</td></tr><tr><td align="right">Significance of difference p**</td><td align="left">0.000</td><td></td><td align="left">0.700</td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><italic>Sex</italic></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="right">male</td><td align="left">0.268</td><td align="left">0.000</td><td align="left">0.359</td><td align="center">0.078</td></tr><tr><td align="right">females</td><td align="left">0.344</td><td align="left">0.000</td><td align="left">0.692</td><td align="center">0.000</td></tr><tr><td align="right">Significance of difference p**</td><td align="left">0.000</td><td></td><td align="left">0.000</td><td></td></tr></tbody></table><table-wrap-foot><p>Significance of difference between correlation coefficients has been calculated according to Snedecor and Cochran. p* refers to significance of correlation coefficient. p** refers to significance of difference between the two classes. For "All subjects" the difference of correlation coefficients between ADA<sub>1</sub>1 and (ADA<sub>1</sub>2/1+ADA<sub>1</sub>2) i.e. 0.289 vs 0.552 is statistically significant: p = 0.04.</p></table-wrap-foot></table-wrap><p>The BW-PW correlation is influenced by environmental and developmental variables, but as shown in tables <xref ref-type="table" rid="T3">3</xref> and <xref ref-type="table" rid="T5">5</xref> the differential effects of ACP<sub>1 </sub>and ADA<sub>1 </sub>phenotypes on this correlation do not appear in general to be significantly influenced by these variables.</p><p>Table <xref ref-type="table" rid="T6">6</xref> shows the correlation between BW and PW according to the joint ACP<sub>1</sub>-ADA<sub>1 </sub>phenotype. Both ADA<sub>1 </sub>and ACP<sub>1 </sub>phenotypes were determined in 327 infants. There is a highly significant difference among joint phenotypes (p = 0.000): the highest correlation is observed in subjects who carry A or CA or CB phenotypes and the ADA<sub>1</sub>*2 allele, while the lowest correlation is observed when the ADA<sub>1 </sub>1 phenotype is associated with B or BA phenotypes.</p><table-wrap position="float" id="T6"><label>Table 6</label><caption><p>Correlation between birth weight (BW) and placental weight (PW) according to the joint ACP<sub>1</sub>-ADA<sub>1 </sub>phenotype.</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="4">Joint ACP<sub>1</sub>-ADA<sub>1 </sub>phenotype</td></tr></thead><tbody><tr><td align="left">Presence of ADA*2 allele</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">+</td></tr><tr><td align="left">Presence of A or CA or CB types</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">+</td></tr><tr><td align="left">BW-PW correlation coefficients (r)</td><td align="center">0.193</td><td align="center" colspan="2">0.613</td><td align="center">0.648</td></tr><tr><td align="left">Significance of r (p)</td><td align="center">0.004</td><td align="center" colspan="2">0.000</td><td align="center">0.059</td></tr><tr><td align="left">Total n&#x000b0;</td><td align="center">217</td><td align="center" colspan="2">101</td><td align="center">9</td></tr></tbody></table><table-wrap-foot><p>Significance of difference among correlation coefficients p = 0.000. Significance of difference among correlation coefficients has been calculated according to Snedecor and Cochran</p></table-wrap-foot></table-wrap></sec><sec><title>Discussion and conclusion</title><p>The present data suggest that foetuses with low ADA<sub>1 </sub>activity, associated with medium-low ACP<sub>1 </sub>F isoform activity, have the best correlation between BW and PW, suggesting a most favourable situation for the development of the feto-placental unit. These observations agree with those expected on the basis of previous data on women with repeated spontaneous miscarriages that demonstrated a cooperative protective effect of ADA<sub>1</sub>*2 and ACP<sub>1</sub>*C alleles against fetal loss. Thus, the two lines of evidence support the hypothesis that foetuses with low ADA<sub>1 </sub>activity and low ACP<sub>1 </sub>F isoform activity have a balanced development of feto-placental unit and a higher probability of survival compared to other foetuses.</p><p>The exact mechanism underlying the statistical association of ADA<sub>1 </sub>and ACP<sub>1 </sub>with the BW-PW correlation is not known at present. An immunological mechanism is supported by the well known relationship between ADA<sub>1 </sub>and immune diseases and between ACP<sub>1 </sub>and T cell activation. A relative depression of T cell activation due to low level of F ACP<sub>1 </sub>isoform and to higher concentration of adenosine (due to the low activity of ADA<sub>1</sub>*2 carriers) could modulate the feto-maternal immunological relationship resulting in a balanced development of the two portions of feto-placental unit.</p><p>A metabolic mechanism may be operative in which ACP<sub>1</sub>, acting as phosphotyrosine phosphatase, could have an important role in the modulation of glycolytic rate through the control of insulin receptor activity and of band 3 protein phosphorylation status. Additionally, catalysing the conversion of flavin-mononucleotide (FMN) in riboflavin, the enzyme may influence flavo-enzyme activity and energy metabolism [<xref ref-type="bibr" rid="B7">7</xref>]. In turn, with respect to ADA<sub>1 </sub>activity, recent studies have shown that adenosine counteracts insulin action in the liver by activating A2B receptors [<xref ref-type="bibr" rid="B20">20</xref>-<xref ref-type="bibr" rid="B22">22</xref>]. On the basis of these actions on glucose metabolism, ACP<sub>1 </sub>F isoform activity coupled with low ADA<sub>1 </sub>activity could have favourable effects on the development of the feto-placental unit.</p><p>Regarding the effect of genetic variability of ACP<sub>1 </sub>on the correlation of BW with PW, it is interesting to speculate on the possible selective advantage of the *A and *C alleles over the *B allele. The *B allele is the most frequent in all human populations, and the *A allele is present with variable frequencies in all major ethnic groups, while *C allele is present with appreciable frequencies only in Caucasians.</p><p>Our data suggest that the optimal BW-PW correlation is seen in carriers of the ACP<sub>1</sub>*C allele and in the homozygous A phenotype (table <xref ref-type="table" rid="T4">4</xref> and Fig <xref ref-type="fig" rid="F1">1</xref>), while the heterozygous BA phenotype shows an intermediate value between B and A (Fig <xref ref-type="fig" rid="F1">1</xref>). Interestingly, in A, CA and CB phenotypes the BW-PW correlation is hardly influenced by environmental circumstances, while in B and BA phenotypes the environmental variables exert considerable effects on this correlation. Thus, ACP<sub>1</sub>*A and *C variants could have a selective advantage during intrauterine life on the fundamental ACP<sub>1</sub>*B allele. This might have contributed to an increase in frequencies of the ACP<sub>1</sub>*A and *C alleles to polymorphic values and could presently contribute to maintenance of the ACP<sub>1 </sub>polymorphism in human populations.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>GBF, BE, MA and BA have been involved in the conception and design of the study, in drafting the manuscript and in its critical revision. GBF and BE have interpreted the data and performed the statistical analyses. PA and CL have contributed to the revision of the manuscript, to the acquisition of the data and to coordination of study. All authors have read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We wish to thank Prof. James MacMurray (Los Angeles, CA) for editing the manuscript.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nicotra</surname><given-names>M</given-names></name><name><surname>Bottini</surname><given-names>N</given-names></name><name><surname>La Torre</surname><given-names>M</given-names></name><name><surname>Amante</surname><given-names>A</given-names></name><name><surname>Bottini</surname><given-names>E</given-names></name><name><surname>Gloria-Bottini</surname><given-names>F</given-names></name></person-group><article-title>Repeated spontaneous abortion. Cooperative effects of ADA and ACP1 genetic polymorphisms</article-title><source>Am J Reprod Immunol</source><year>2007</year><volume>58</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">17565542</pub-id><pub-id pub-id-type="doi">10.1111/j.1600-0897.2007.00483.x</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname><given-names>DJP</given-names></name><name><surname>Bull</surname><given-names>AR</given-names></name><name><surname>Osmond</surname><given-names>C</given-names></name><name><surname>Simmonds</surname><given-names>SJ</given-names></name></person-group><article-title>Fetal and placental size and risk of hypertension in adult life</article-title><source>BMJ</source><year>1990</year><volume>301</volume><fpage>259</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">2390618</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>A</given-names></name><name><surname>Megrens</surname><given-names>A</given-names></name><name><surname>Peek</surname><given-names>M</given-names></name><name><surname>Wallace</surname><given-names>EM</given-names></name></person-group><article-title>Sexual origins of placental dysfunction</article-title><source>Lancet</source><year>2000</year><volume>355</volume><fpage>203</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">10675126</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(99)05061-8</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>LA</given-names></name><name><surname>Evans</surname><given-names>SF</given-names></name><name><surname>Newnham</surname><given-names>JP</given-names></name></person-group><article-title>Prospective cohort study of factors influencing the relative weights of the placenta and the newborn infant</article-title><source>BMJ</source><year>1997</year><volume>314</volume><fpage>1864</fpage><lpage>1871</lpage><pub-id pub-id-type="pmid">9224128</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sivarao</surname><given-names>S</given-names></name><name><surname>Viyadaran</surname><given-names>MK</given-names></name><name><surname>Jammal</surname><given-names>AB</given-names></name><name><surname>Zainab</surname><given-names>S</given-names></name><name><surname>Goh</surname><given-names>YM</given-names></name><name><surname>Rames</surname><given-names>KN</given-names></name></person-group><article-title>Weight, volume and surface area of placenta of normal pregnant women and their relation to maternal and neonatal parameters in Malay, Chinese and Indian ethnic groups</article-title><source>Placenta</source><year>2002</year><volume>23</volume><fpage>691</fpage><lpage>696</lpage><pub-id pub-id-type="pmid">12361688</pub-id><pub-id pub-id-type="doi">10.1053/plac.2002.0817</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gloria-Bottini</surname><given-names>F</given-names></name><name><surname>Bottini</surname><given-names>N</given-names></name><name><surname>Cosmi</surname><given-names>E</given-names></name><name><surname>Cosmi</surname><given-names>EV</given-names></name><name><surname>Bottini</surname><given-names>E</given-names></name></person-group><article-title>The effect of gender and ACP1 genetic polymorphism on the correlation between birth weight and placental weight</article-title><source>Placenta</source><year>2005</year><volume>26</volume><fpage>846</fpage><lpage>848</lpage><pub-id pub-id-type="pmid">16226135</pub-id><pub-id pub-id-type="doi">10.1016/j.placenta.2004.12.002</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bottini</surname><given-names>N</given-names></name><name><surname>Bottini</surname><given-names>E</given-names></name><name><surname>Gloria-Bottini</surname><given-names>F</given-names></name><name><surname>Mustelin</surname><given-names>T</given-names></name></person-group><article-title>Low-molecular-weight protein tyrosine phosphatase and human disease: in search of biochemical mechanisms</article-title><source>Arch Immunol Therap Exp</source><year>2002</year><volume>50</volume><fpage>95</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">12022706</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>N</given-names></name><name><surname>Hopkinson</surname><given-names>DA</given-names></name><name><surname>Harris</surname><given-names>H</given-names></name></person-group><article-title>Quantitative differences and gene dosage in the human red cell acid phosphatise polymorphism</article-title><source>Nature</source><year>1964</year><volume>201</volume><fpage>299</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">14110459</pub-id><pub-id pub-id-type="doi">10.1038/201299a0</pub-id></citation></ref><ref id="B9"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Dissing</surname><given-names>J</given-names></name></person-group><article-title>Human red cell acid phosphatase (ACP1) genetic, catalytic and molecular properties</article-title><source>PhD thesis</source><year>1993</year><publisher-name>Kobenhavn Universitat, Kobenhavn, Denmark</publisher-name></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dissing</surname><given-names>J</given-names></name></person-group><article-title>Immunochemical characterization of human red cell acid phosphatase isoozymes</article-title><source>Biochem Genet</source><year>1987</year><volume>25</volume><fpage>901</fpage><lpage>917</lpage><pub-id pub-id-type="pmid">3130837</pub-id><pub-id pub-id-type="doi">10.1007/BF00502609</pub-id></citation></ref><ref id="B11"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Mansfield</surname><given-names>E</given-names></name><name><surname>Sensabaugh</surname><given-names>GF</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Brewer GJ</surname></name></person-group><article-title>Red cell acid phosphatase: modulation of activity by purines</article-title><source>The red cell</source><year>1978</year><volume>21</volume><publisher-name>Allan R. Liss. New York</publisher-name><fpage>233</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">662892</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boivin</surname><given-names>P</given-names></name><name><surname>Galand</surname><given-names>C</given-names></name></person-group><article-title>The human red cell acid phosphatase is a phosphotyrosine protein phosphatase which dephosphorylates the membrane protein band 3</article-title><source>Biochem Biophys Res Commun</source><year>1986</year><volume>134</volume><fpage>557</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">2418829</pub-id><pub-id pub-id-type="doi">10.1016/S0006-291X(86)80456-9</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>KR</given-names></name><name><surname>Shekels</surname><given-names>LL</given-names></name><name><surname>Bernlohr</surname><given-names>DA</given-names></name></person-group><article-title>Analysis of the ACP 1 gene product-classification as an FMN phosphatase</article-title><source>Biochem Biophys Res Commun</source><year>1992</year><volume>189</volume><fpage>1598</fpage><lpage>1605</lpage><pub-id pub-id-type="pmid">1336375</pub-id><pub-id pub-id-type="doi">10.1016/0006-291X(92)90259-N</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gloria-Bottini</surname><given-names>F</given-names></name><name><surname>Gerlini</surname><given-names>G</given-names></name><name><surname>Lucarini</surname><given-names>N</given-names></name><name><surname>Borgiani</surname><given-names>P</given-names></name><name><surname>Amante</surname><given-names>A</given-names></name><name><surname>La Torre</surname><given-names>M</given-names></name><name><surname>Antonacci</surname><given-names>E</given-names></name><name><surname>Bottini</surname><given-names>E</given-names></name></person-group><article-title>Phosphotyrosine protein phosphatases and diabetic pregnancy. An association between low molecular weight acid phosphatase (ACP1) and degree of glycemic control</article-title><source>Experientia</source><year>1996</year><volume>52</volume><fpage>340</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">8620937</pub-id><pub-id pub-id-type="doi">10.1007/BF01919537</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lucarini</surname><given-names>N</given-names></name><name><surname>Antonacci</surname><given-names>E</given-names></name><name><surname>Bottini</surname><given-names>N</given-names></name><name><surname>Borgiani</surname><given-names>P</given-names></name><name><surname>Faggioni</surname><given-names>G</given-names></name><name><surname>Gloria-Bottini</surname><given-names>F</given-names></name></person-group><article-title>Phosphotyrosine-protein phosphatase and diabetic disordes. Further studies on the relationship between low molecular weight acid phosphatase genotype and degree of glycemic control</article-title><source>Disease Markers</source><year>1998</year><volume>14</volume><fpage>121</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">9868599</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bottini</surname><given-names>N</given-names></name><name><surname>Stefanini</surname><given-names>L</given-names></name><name><surname>Williams</surname><given-names>S</given-names></name><name><surname>Alonso</surname><given-names>A</given-names></name><name><surname>Jascur</surname><given-names>T</given-names></name><name><surname>Abraham</surname><given-names>RT</given-names></name><name><surname>Couture</surname><given-names>C</given-names></name><name><surname>Mustelin</surname><given-names>T</given-names></name></person-group><article-title>Activation of ZAP-70 through specific dephosphorylation at the inhibitory Tyr-292 by the low molecular weight phosphotyrosine phosphatase (LMPTP)</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>24220</fpage><lpage>24224</lpage><pub-id pub-id-type="pmid">11976341</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M202885200</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>N</given-names></name><name><surname>Hopkinson</surname><given-names>D</given-names></name><name><surname>Harris</surname><given-names>H</given-names></name></person-group><article-title>Adenosine deaminase polymorphism in man</article-title><source>Ann Hum Genet</source><year>1968</year><volume>32</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1111/j.1469-1809.1968.tb00044.x</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Battistuzzi</surname><given-names>C</given-names></name><name><surname>Scozzari</surname><given-names>R</given-names></name><name><surname>Santolamazza</surname><given-names>P</given-names></name><name><surname>Terrenato</surname><given-names>L</given-names></name><name><surname>Modiano</surname><given-names>G</given-names></name></person-group><article-title>Comparative actvity of red cell adenosine deaminase allelic forms</article-title><source>Nature</source><year>1974</year><volume>251</volume><fpage>712</fpage><pub-id pub-id-type="doi">10.1038/251711a0</pub-id></citation></ref><ref id="B19"><citation citation-type="book"><person-group person-group-type="author"><name><surname>McKusik</surname><given-names>VA</given-names></name></person-group><source>Mendelian Inheritance in Man</source><year>1994</year><edition>11</edition><publisher-name>Baltimore, MD, The Johns Hokins University Press</publisher-name></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Berkich</surname><given-names>DA</given-names></name><name><surname>Crist</surname><given-names>Gh</given-names></name><name><surname>LaNoue</surname><given-names>KF</given-names></name></person-group><article-title>A<sub>1 </sub>adenosine receptor antagonism improves glucose tolerance in Zucker rats</article-title><source>Am J Physiol</source><year>1998</year><volume>274</volume><fpage>E271</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">9486158</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>PJ</given-names></name></person-group><article-title>Blocking adenosine with antisense</article-title><source>Nature</source><year>1997</year><volume>385</volume><fpage>684</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">9034184</pub-id><pub-id pub-id-type="doi">10.1038/385684b0</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yasuda</surname><given-names>N</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Horizoe</surname><given-names>T</given-names></name><name><surname>Nagata</surname><given-names>K</given-names></name><name><surname>Minami</surname><given-names>H</given-names></name><name><surname>Kawata</surname><given-names>T</given-names></name><name><surname>Hoshino</surname><given-names>Y</given-names></name><name><surname>Harada</surname><given-names>H</given-names></name><name><surname>Yoshikawa</surname><given-names>S</given-names></name><name><surname>Asano</surname><given-names>O</given-names></name><name><surname>Nagaoka</surname><given-names>J</given-names></name><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Abe</surname><given-names>S</given-names></name><name><surname>Kobayashi</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>I</given-names></name></person-group><article-title>Functional characterization of the adenosine receptor contributing to glycogenolysis and gluconeogenesis in rat hepatocytes</article-title><source>Eur J Pharmacol</source><year>2003</year><volume>459</volume><fpage>159</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">12524141</pub-id><pub-id pub-id-type="doi">10.1016/S0014-2999(02)02832-7</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kameoka</surname><given-names>J</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Nojima</surname><given-names>Y</given-names></name><name><surname>Schlossman</surname><given-names>SF</given-names></name><name><surname>Morimoto</surname><given-names>C</given-names></name></person-group><article-title>Direct association of adenosine deaminase with T cell activation antigen CD26</article-title><source>Science</source><year>1993</year><volume>261</volume><fpage>466</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">8101391</pub-id><pub-id pub-id-type="doi">10.1126/science.8101391</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>RP</given-names></name><name><surname>Kameoka</surname><given-names>J</given-names></name><name><surname>Hegen</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Schlossman</surname><given-names>SF</given-names></name><name><surname>Morimoto</surname><given-names>C</given-names></name></person-group><article-title>Characterization of adenosin deaminase binding to human CD26 on T cells and its biologic role in immune response</article-title><source>J Immunol</source><year>1996</year><volume>156</volume><fpage>1349</fpage><lpage>1355</lpage><pub-id pub-id-type="pmid">8568233</pub-id></citation></ref><ref id="B25"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>H</given-names></name><name><surname>Hopkinson</surname><given-names>DA</given-names></name></person-group><source>Handbook of enzyme electrophoresis in human genetics</source><year>1976</year><publisher-name>Amsterdam: Elsevier</publisher-name></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>N</given-names></name><name><surname>Hopkinson</surname><given-names>D</given-names></name><name><surname>Harris</surname><given-names>H</given-names></name></person-group><article-title>Adenosin deaminase polymorphism in man</article-title><source>Ann Hum Genet</source><year>1968</year><volume>32</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1111/j.1469-1809.1968.tb00044.x</pub-id></citation></ref><ref id="B27"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Snedecor</surname><given-names>GW</given-names></name><name><surname>Cochran</surname><given-names>WG</given-names></name></person-group><source>Statistical methods</source><year>1989</year><publisher-name>Ames: Iowa State University</publisher-name></citation></ref></ref-list></back></article> 